Pionyr Immunotherapeutics
Biotechnology, 2 Tower Pl Ste 800, South San Francisco, California, 94080, United States, 51-200 Employees
Phone Number: 65********
Who is PIONYR IMMUNOTHERAPEUTICS
In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need. We are a clinical stage company discovering and developing novel anti...
Read More
-
Headquarters: 2 Tower Pl Ste 800, South San Francisco, California, 94080, United States
-
Date Founded: 2015
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from PIONYR IMMUNOTHERAPEUTICS
Pionyr Immunotherapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Pionyr Immunotherapeutics
Answer: Pionyr Immunotherapeutics's headquarters are located at 2 Tower Pl Ste 800, South San Francisco, California, 94080, United States
Answer: Pionyr Immunotherapeutics's phone number is 65********
Answer: Pionyr Immunotherapeutics's official website is https://pionyrtx.com
Answer: Pionyr Immunotherapeutics's revenue is $1 Million to $5 Million
Answer: Pionyr Immunotherapeutics's SIC: 2836
Answer: Pionyr Immunotherapeutics's NAICS: 541714
Answer: Pionyr Immunotherapeutics has 51-200 employees
Answer: Pionyr Immunotherapeutics is in Biotechnology
Answer: Pionyr Immunotherapeutics contact info: Phone number: 65******** Website: https://pionyrtx.com
Answer: In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need. We are a clinical stage company discovering and developing novel antibody therapeutics that dramatically alter the tumor microenvironment (TME) and enhance the bodys immune defense against cancer with the potential to eliminate it. Pionyr's Myeloid TuningTM cutting-edge technology is based on the discovery that tuning the tumor microenvironment to favor immune-activating cells and disable immune-suppressing cells improves the bodys ability to combat cancer, particularly in combination with checkpoint inhibitors. Additionally, Pionyr is building a pipeline of transmembrane and intracellular targets using our cutting-edge technologies and translational assays. Immuno-oncology is a complex field, which is why Pionyr has recruited a bold and growing team with extensive experience in immunology, immuno-oncology, target discovery, and immunotherapy development. Our Pionyrs are banded together by innovation, integrity, team empowerment, respect and one unified voice to translate meaningful science into promising opportunities for treating cancer.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month